DUSA Pharmaceuticals was an American pharmaceutical company with dermatology products, including Levulan and Nicomide. It was acquired by Sun Pharma in 2012 and the brand continues as DUSA Dermatology within the Sun Pharma company.
History
In the first quarter of 2006, DUSA Pharmaceuticals obtained Sirius Laboratories in a merger estimated to be worth 30 million dollars. Sirius was a privately held dermatology specialty pharmaceuticals company founded by Dr. Joel E. Bernstein in 2000 dedicated to the treatment of acne vulgaris and acne rosacea.[1]
In 2012, Caraco Pharmaceutical Laboratories (CPL), a subsidiary of Sun Pharmaceutical, acquired DUSA.[2][3]